EUVIMEDEUVIMED entdecken
Crossref

Severe cutaneous adverse drug reactions: A search for the culprit in a retrospective study of 107 patients

Ghita Sqalli Houssini, Zakia Douhi, Meryem Soughi, Sara Elloudi, Hanane Baybay, Badreddine Moukafih, Marwa Elbaldi, Karima El Rhazi El Rhazi, Fatima Zahra Mernissi

Our Dermatology Online · 03.01.2025 · 16 (1)

DOI: 10.7241/ourd.20251.6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Our Dermatology Online, online erschienen am 03.01.2025. Verfasst von Ghita Sqalli Houssini und 8 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Severe drug eruptions, posing life-threatening risks, necessitate immediate discontinuation.This study (2014)(2015)(2016)(2017)(2018)(2019)(2020)(2021)(2022)(2023) examined clinical profiles and prognoses in Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome, Stevens-Johnson (SJS) syndrome, Toxic Epidermal Necrolysis (Lyell's syndrome), and Acute Generalized Exanthematous Pustulosis (AGEP).Materials and Methods: A retrospective analysis included hospitalized patients with severe drug reactions.

Results

Implicated drugs: allopurinol (44.9%), neuroleptics (20.6%), antibiotics (12.1%), sulfasalazine (5.6%), and NSAIDs (5.6%).Allopurinol dominated in DRESS syndrome (51.4%),SJS (35.3%),Lyell's syndrome (45.5%).Neuroleptics caused SJS (35.3%),Lyell's syndrome (27.3%), and DRESS syndrome (18.1%).Antibiotics linked to AGEP (28.6%),SJS (17.6%),Lyell's syndrome (9.1%), and DRESS syndrome (9.7%).Sulfasalazine was associated with SJS (9.0%) and DRESS syndrome (6.9%), NSAIDs with AGEP (42.9%), and DRESS syndrome (4.2%).Significant correlations included sulfasalazine with hepatic impairment and allopurinol, neuroleptics, and antibiotics with renal failure.Mortality was 9.3%, primarily from allopurinol (60%), antibiotics (20%), and sulfasalazine (20%).

Conclusion

Allopurinol and neuroleptics pose higher risks with significant correlations to severe complications.Haut du formulaire.

Zitieren

APA

Houssini, G. S., Douhi, Z., Soughi, M., Elloudi, S., Baybay, H., Moukafih, B., Elbaldi, M., Rhazi, K. E. R. E., & Mernissi, F. Z. (2025). Severe cutaneous adverse drug reactions: A search for the culprit in a retrospective study of 107 patients. Our Dermatology Online, 16(1). https://doi.org/10.7241/ourd.20251.6

Vancouver

Houssini GS, Douhi Z, Soughi M, Elloudi S, Baybay H, Moukafih B, et al. Severe cutaneous adverse drug reactions: A search for the culprit in a retrospective study of 107 patients. Our Dermatology Online. 2025;16(1). doi:10.7241/ourd.20251.6

BibTeX
@article{Houssini2025,
  author = {Houssini, Ghita Sqalli and Douhi, Zakia and Soughi, Meryem and Elloudi, Sara and Baybay, Hanane and Moukafih, Badreddine and Elbaldi, Marwa and Rhazi, Karima El Rhazi El and Mernissi, Fatima Zahra},
  title = {Severe cutaneous adverse drug reactions: A search for the culprit in a retrospective study of 107 patients},
  journal = {Our Dermatology Online},
  year = {2025},
  volume = {16},
  number = {1},
  doi = {10.7241/ourd.20251.6}
}
Kostenlos starten →